Cancer test receives breakthrough status

2021-10-25

Biological Dynamics has received breakthrough status designation from the FDA for its Exo-PDAC that is used for the early detection of pancreatic ductal adenocarcinoma. "For far too long, patients have needed innovative technologies with the potential to detect cancer at the earliest stages, and we look forward to working closely with the FDA, to do exactly that," said CEO Raj Krishnan.

Full story:

AdvaMed SmartBrief

Medical devices, health care information systems and diagnostic products

Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart.